Dr. Eric Yang is an experienced professional in drug development, utilizing ML/AI and other computational tools to efficiently retarget therapies to new patients. He has experience in drug development at major pharmaceutical companies such as J&J and Novartis as well as experience in the payor space at Aetna. Currently, he is at Medidata Solutions developing new ways of leveraging LLM and traditional ML methods in drug development